Digistain Technology Features & Advantages
Traditional risk profiling tests are expensive and time consuming. Digistain combats this by providing a cheaper, faster, more accessible alternative to deliver a robust and personalised risk score for cancer therapy guidance.
PROVEN – clinically validated predictive power, designed for integration within histopathology workflows to support MDT risk stratification
FAST – takes less than one hour with results quickly returned to the healthcare provider, thereby cutting decision times from months and weeks to days
COST-EFFECTIVE – unlike traditional tumour profiling technologies, Digistain is reagent free, allowing it to operate at a fraction of the cost
ACCESSIBLE – low-cost process and fast turnaround enables more patients to access the best care
CLEAR – provides an easy-to-read pathology report with a clear low or high-risk score on the likelihood of breast cancer recurrence in the next 5-10 years
PRECISE – Delivers prognostic accuracy through spectroscopic-derived tissue features, capturing tumour structural and organisational characteristics — avoiding the tissue processing variability and reproducibility issues associated with traditional genomic tests
APPLICABLE – has broad ethnic applicability and is suitable for people all around the world
COMPATIBLE – works with current hospital diagnostic workflows, supported by robust quality management systems, and applied to already available tumour samples prepared using standard processing methods
ENVIROMENTAL – Avoids the high carbon footprint associated with genomic tests that require large volumes of chemical reagents — and where centralised processing can introduce logistical dependencies, including international air shipment of samples
No change to workflow using Digistain®
